Dublin-based pharmaceutical group Shire on Tuesday said it has bid $30 billion (27 billion euros) for US rival Baxalta to form a global biotech company focused on rare diseases.
"We believe the proposed combination of Shire and Baxalta would be strategically and financially attractive for both of our companies, accelerating our respective growth ambitions and creating the leading global biotech company in rare diseases," Shire's Chief Executive Officer Flemming Ornskov said in a statement.
GMT 12:07 2018 Tuesday ,23 January
Syria Kurds urge civilians to take up arms against Turk assaultGMT 12:03 2018 Tuesday ,23 January
Egypt military accuses presidential hopeful of crimes including forgeryGMT 11:41 2018 Tuesday ,23 January
UK regulator says Fox's Sky takeover 'not in public interest'GMT 11:38 2018 Tuesday ,23 January
South African jazz legend Hugh Masekela diesGMT 11:36 2018 Tuesday ,23 January
EU removes eight countries from tax haven listGMT 11:32 2018 Tuesday ,23 January
8.2 magnitude quake hits off Alaska: USGSGMT 11:28 2018 Tuesday ,23 January
Mattis calls for Turkish 'restraint' in SyriaGMT 03:43 2018 Tuesday ,23 January
Turkish soldier killed in Syria operation: armyMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor